Updated Jul 16, 2026
Chevallard Daniel R. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $64K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-30 | LENZ | LENZ Therapeutics, Inc. | P — Open-market purchase | 7.5K | $8.57 | $64K |
Chevallard Daniel R. is a corporate insider — currently tracked as Chief Financial Officer. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($64K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chevallard Daniel R. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.